Among 89 patients evaluated at baseline (days 0-6), Spike-directed IgG, IgM, and IgA seroconversion rates increased from 57.3%, 66.3%, and 42.7% to 88%, 66%, and 34%, by week 5 post-infection, respectively (Figure 2A). This evidence concerns the gene CD79A and infection.